C35H49NO10
Neat
643.8
Buprenorphine 3-Glucuronide; 101224-22-0; L7FYM9GI97; Buprenorphine-3-O-glucuronide; Buprenorphine Glucuronide; RefChem:917717; (2S, 3S, 4S, 5R, 6S)-6-[[(1S, 2S, 6R, 14R, 15R, 16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3, 3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12, 8.01, 6.02, 14.012, 20]icosa-8(20), 9, 11-trien-11-yl]oxy]-3, 4, 5-trihydroxyoxane-2-carboxylic acid; Buprenorphine-3-Beta-D-glucuronide; UNII-L7FYM9GI97; Buprenorphine beta-D-Glucuronide (100ug/ml in Methanol); Buprenorphine 3-beta-D-Glucuronide; B-3-G; Buprenorphine 3-beta-D-Glucuronide; Buprenorphine 3-glucuronide; Buprenorphine 3-ss-D-glucuronide; Buprenorphine glucuronide; (5a, 7a)-17-(Cyclopropylmethyl)-4, 5-epoxy-18, 19-dihydro-7-[(1S)-1-hydroxy-1, 2, 2-trimethylpropyl]-6-methoxy-6, 14-ethenomorphinan-3-yl ss-D-glucopyranosiduronic acid; Buprenorphine Beta-D-Glucuronide; SCHEMBL27142462; BUPRENORPHINE-3B-D-GLUCURONIDE; BUPRENORPHINE 3-.BETA.-D-GLUCURONIDE; Q27282811; Buprenorphine-3-Beta-D-glucuronide and 0.1mg/ml in Methanol; Buprenorphine 3-beta-D-Glucuronide 0.1 mg/ml in Methanol
(2S, 3S, 4S, 5R, 6S)-6-[[(1S, 2S, 6R, 14R, 15R, 16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3, 3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12, 8.01, 6.02, 14.012, 20]icosa-8(20), 9, 11-trien-11-yl]oxy]-3, 4 and 5-trihydroxyoxane-2-carboxylic acid
InChI=1S/C35H49NO10/c1-31(2,3)32(4,42)20-15-33-10-11-35(20,43-5)30-34(33)12-13-36(16-17-6-7-17)21(33)14-18-8-9-19(26(46-30)22(18)34)44-29-25(39)23(37)24(38)27(45-29)28(40)41/h8-9,17,20-21,23-25,27,29-30,37-39,42H,6-7,10-16H2,1-5H3,(H,40,41)/t20-,21-,23+,24+,25-,27+,29-,30-,32+,33-,34+,35-/m1/s1